| Report Title | Price | Action |
|---|---|---|
| Respiratory Syncytial Virus Fusion Protein (RSV F Protein) - Drugs in Development, 2021
Respiratory Syncytial Virus Fusion Protein (RSV F Protein) - Drugs in Development, 2021 Summary Respiratory Syncytial Virus Fusion Protein (RSV F Pr...
Published: Apr-2021 | No. of Pages: 95
|
$ 3000 | |
| Hemoglobinopathies (Hematological Disorders) - Drugs in Development, 2021
Hemoglobinopathies (Hematological Disorders) - Drugs in Development, 2021 Summary Hemoglobinopathies (Hematological Disorders) - Drugs in Developmen...
Published: Apr-2021 | No. of Pages: 30
|
$ 2000 | |
| Antithrombin III (ATIII or SERPINC1) - Drugs in Development, 2021
Antithrombin III (ATIII or SERPINC1) - Drugs in Development, 2021 Summary Antithrombin III (ATIII or SERPINC1) - Drugs in Development, 2021 provides...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
| Cells Expressing Tumor Necrosis Factor Receptor Superfamily Member 17 (B Cell Maturation Antigen or CD269 or BCMA or TNFRSF17) - Drugs in Development, 2021
Cells Expressing Tumor Necrosis Factor Receptor Superfamily Member 17 (B Cell Maturation Antigen or CD269 or BCMA or TNFRSF17) - Drugs in Development,...
Published: Apr-2021 | No. of Pages: 220
|
$ 3500 | |
| Interleukin 1 Receptor Accessory Protein (Interleukin 1 Receptor 3 or IL1R3 or IL1RAP) - Drugs in Development, 2021
Interleukin 1 Receptor Accessory Protein (Interleukin 1 Receptor 3 or IL1R3 or IL1RAP) - Drugs in Development, 2021 Summary Interleukin 1 Receptor A...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
| Plasminogen (Plasmin or PLG or EC 3.4.21.7) - Drugs in Development, 2021
Plasminogen (Plasmin or PLG or EC 3.4.21.7) - Drugs in Development, 2021 Summary Plasminogen (Plasmin or PLG or EC 3.4.21.7) - Drugs in Development,...
Published: Apr-2021 | No. of Pages: 50
|
$ 3000 | |
| Congenital Adrenal Hyperplasia (Adrenogenital Syndrome) (Hormonal Disorders) - Drugs in Development, 2021
Congenital Adrenal Hyperplasia (Adrenogenital Syndrome) (Hormonal Disorders) - Drugs in Development, 2021 Summary Congenital Adrenal Hyperplasia (Ad...
Published: Apr-2021 | No. of Pages: 30
|
$ 2000 | |
| Refractory Acute Myeloid Leukemia (Oncology) - Drugs in Development, 2021
Refractory Acute Myeloid Leukemia (Oncology) - Drugs in Development, 2021 Summary Refractory Acute Myeloid Leukemia (Oncology) - Drugs in Developmen...
Published: Apr-2021 | No. of Pages: 425
|
$ 2500 | |
| Apoptosis Associated Speck Like Protein Containing A CARD (Caspase Recruitment Domain Containing Protein 5 or PYD And CARD Domain Containing Protein or Target Of Methylation Induced Silencing 1 or ASC or PYCARD) - Drugs in Development, 2021
Apoptosis Associated Speck Like Protein Containing A CARD (Caspase Recruitment Domain Containing Protein 5 or PYD And CARD Domain Containing Protein o...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
| Insulin Receptor (IR or CD220 or INSR or EC 2.7.10.1) - Drugs in Development, 2021
Insulin Receptor (IR or CD220 or INSR or EC 2.7.10.1) - Drugs in Development, 2021 Summary Insulin Receptor (IR or CD220 or INSR or EC 2.7.10.1) - D...
Published: Apr-2021 | No. of Pages: 230
|
$ 3500 | |
| Interleukin 17F (Cytokine ML 1 or IL17F) - Drugs in Development, 2021
Interleukin 17F (Cytokine ML 1 or IL17F) - Drugs in Development, 2021 Summary Interleukin 17F (Cytokine ML 1 or IL17F) - Drugs in Development, 2021 ...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
| HIV 1 Integrase (EC 2.7.7.) - Drugs in Development, 2021
HIV 1 Integrase (EC 2.7.7.) - Drugs in Development, 2021 Summary HIV 1 Integrase (EC 2.7.7.) - Drugs in Development, 2021 provides in depth analysis...
Published: Apr-2021 | No. of Pages: 45
|
$ 3000 | |
| Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) (Immunology) - Drugs in Development, 2021
Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) (Immunology) - Drugs in Development, 2021 Summary Chronic Cutaneous...
Published: Apr-2021 | No. of Pages: 30
|
$ 2000 | |
| Refractory Chronic Lymphocytic Leukemia (CLL) (Oncology) - Drugs in Development, 2021
Refractory Chronic Lymphocytic Leukemia (CLL) (Oncology) - Drugs in Development, 2021 Summary Refractory Chronic Lymphocytic Leukemia (CLL) (Oncolog...
Published: Apr-2021 | No. of Pages: 170
|
$ 2000 | |
| Ataxin 3 (Machado Joseph Disease Protein 1 or Spinocerebellar Ataxia Type 3 Protein or SCA3 or ATXN3 or EC 3.4.19.12) - Drugs in Development, 2021
Ataxin 3 (Machado Joseph Disease Protein 1 or Spinocerebellar Ataxia Type 3 Protein or SCA3 or ATXN3 or EC 3.4.19.12) - Drugs in Development, 2021 Su...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
| Tumor Necrosis Factor (Cachectin or TNF Alpha or Tumor Necrosis Factor Ligand Superfamily Member 2 or TNF a or TNF) - Drugs in Development, 2021
Tumor Necrosis Factor (Cachectin or TNF Alpha or Tumor Necrosis Factor Ligand Superfamily Member 2 or TNF a or TNF) - Drugs in Development, 2021 Summ...
Published: Apr-2021 | No. of Pages: 230
|
$ 3500 | |
| Interleukin 18 (Interferon Gamma Inducing Factor or Iboctadekin or Interleukin 1 Gamma or IL18) - Drugs in Development, 2021
Interleukin 18 (Interferon Gamma Inducing Factor or Iboctadekin or Interleukin 1 Gamma or IL18) - Drugs in Development, 2021 Summary Interleukin 18 ...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
| Interleukin 1 Alpha (IL 1 Alpha or Hematopoietin 1 or IL1A) - Drugs in Development, 2021
Interleukin 1 Alpha (IL 1 Alpha or Hematopoietin 1 or IL1A) - Drugs in Development, 2021 Summary Interleukin 1 Alpha (IL 1 Alpha or Hematopoietin 1 ...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
| Immunoglobulin G4-Related Disease (IgG4-RD) (Immunology) - Drugs in Development, 2021
Immunoglobulin G4-Related Disease (IgG4-RD) (Immunology) - Drugs in Development, 2021 Summary Immunoglobulin G4-Related Disease (IgG4-RD) (Immunolog...
Published: Apr-2021 | No. of Pages: 30
|
$ 2000 | |
| Refractory Multiple Myeloma (Oncology) - Drugs in Development, 2021
Refractory Multiple Myeloma (Oncology) - Drugs in Development, 2021 Summary Refractory Multiple Myeloma (Oncology) - Drugs in Development, 2021 prov...
Published: Apr-2021 | No. of Pages: 425
|
$ 2500 |